To make an appointment, please call 1-800-KARMANOS (1-800-527-6266) or request an appointment online
As a leader in cancer research, Karmanos is able to offer patients access to innovative treatments and clinical trials that are often times not available anywhere else.
To offer hope and longer life to patients with all types of cancer, Karmanos offers the latest types of therapy through our clinical trials program. Through clinical trials, we are creating new knowledge about how therapies fight cancer and provide national leadership in testing these new therapies.
We understand that cancer is a complex disease that demands complex care. We provide each patient with a dynamic, carefully constructed treatment plan focused on their specific cancer and their unique needs.
We listen to you to design a plan that provides you with respect, compassionate care and is responsive to your emotional and practical concerns.
WJR
The FDA has issued a ban on using Red Dye No. 3 as an ingredient in food and drinks in the U.S. This ban doesn’t take effect until “January 15, 2027, or January 15, 2028, respectively,” as stated in the constituent update on the FDA’s website. Wasif Saif, M.D., MBBS, medical oncologist, leader of the Phase I Clinical Trials Multidisciplinary Team (MDT), and co-leader of the Gastrointestinal and Neuroendocrine Oncology MDT, gave some tips on how you can try to avoid this ingredient in your food and drinks until the ban takes place.
Your browser does not support the audio element.
Download Podcast